Corrigendum to “Design, synthesis, and biological evaluation of novel tetrahydroprotoberberine derivatives to reduce SREBPs expression for the treatment of hyperlipidemia” [Eur. J. Med. Chem. 221 (2021) 113522]
- Resource Type
- Erratum
- Source
- In
European Journal of Medicinal Chemistry 15 January 2022 228 - Subject
- Language
- ISSN
- 0223-5234